Sun Pharma acquires three anti-inflammatory brands from Aksigen Hospital Care

30 Jan 2023 Evaluate

Sun Pharmaceutical Industries has acquired three anti-inflammatory brands from Mumbai-based Aksigen Hospital Care. The company has acquired Disperzyme, Disperzyme-CD and Phlogam as part of the deal.

All the brands are approved by the Drugs Controller General of India (DCGI) for post-operative inflammation in patients undergoing minor surgery and dental procedures. Disperzyme and Phlogam are the first enzyme-bioflavonoid combinations of Trypsin, Bromelain and Rutoside to complete a clinical study in India and get DCGI approval.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1790.05 -14.90 (-0.83%)
08-Dec-2025 15:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1790.05
Dr. Reddys Lab 1272.70
Cipla 1498.90
Zydus Lifesciences 920.90
Lupin 2061.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×